Artios initiates Phase 2 study of Polθ Inhibitor ART4215 in Combination with PARP Inhibitor Talazoparib in BRCA Deficient Breast Cancer
| Press release
News & Events
Benchtop Bios Podcast featuring Dr. Graeme Smith
| Media coverage
Artios Appoints Samantha Truex to Board of Directors
| Press release
Artios Announces ATR Inhibitor, ART0380, Development On Track and Progressing Into Phase 1b Evaluation
| Press release
Artios attending the AACR in New Orleans 8-12 April 2022
| Conferences
Graeme Smith, CSO and Helen Robinson, VP Biology attending the 5th Digital DDR, ATR, & PARP Summit – 25/26 January 2022
| Conferences
